Tumor necrosis factor alpha stimulates leukotriene production in vivo.
Tumor necrosis factor alpha, or cachectin (TNF), is a polypeptide mediator with proinflammatory and antitumor actions. It is produced in large amounts by lipopolysaccharide (LPS)-activated macrophages. TNF as well as LPS stimulated the arachidonate cascade leading to the synthesis of leukotrienes (LT) in vivo. Production of endogenous cysteinyl LT was measured in anesthetized rat using the biliary excretion of N-acetyl-LTE4 as an indicator. Infusion of TNF over a 1-h period greatly increased the rate of cysteinyl LT production during the subsequent 3 h. Pretreatment with anti-TNF antibody F(ab')2 fragments prevented enhanced LT generation as well as tachypnea (a sign of the in vivo action of TNF). LT production elicited by TNF was similar to that evoked by infusion of LPS. Our results indicate that lipoxygenase products are involved in the network of pathophysiological events induced by TNF. The proinflammatory and shock-inducing LT may mediate many of the adverse effects of TNF in vivo as well as its antitumor action.
Huber
M
M
Division of Tumor Biochemistry, Deutsches Krebsforschungszentrum, Heidelberg, FRG.
Beutler
B
B
Keppler
D
D
D000818:Animals; D001646:Bile / Q000378:metabolism; D005260:Female; D017999:Leukotriene E4; D015289:Leukotrienes / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000494:pharmacology; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013189:SRS-A / Q000031:analogs & derivatives / Q000096:biosynthesis; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D015289:Leukotrienes; D008070:Lipopolysaccharides; D013189:SRS-A; D014409:Tumor Necrosis Factor-alpha; D017999:Leukotriene E4